Pulmonary mucormycosis in a patient with acute liver failure: A case report and systematic review of the literature.


Journal

Journal of critical care
ISSN: 1557-8615
Titre abrégé: J Crit Care
Pays: United States
ID NLM: 8610642

Informations de publication

Date de publication:
04 2020
Historique:
received: 13 10 2019
revised: 05 12 2019
accepted: 11 12 2019
pubmed: 28 12 2019
medline: 2 3 2021
entrez: 28 12 2019
Statut: ppublish

Résumé

Pulmonary mucormycosis is a highly lethal invasive fungal infection usually found in immunocompromised patients. We report herein the case of an adult woman who developed pulmonary mucormycosis with possible systemic dissemination after recovering from acute liver failure secondary to acetaminophen overdose. Our case developed an invasive pulmonary mucormycosis with probable systemic dissemination. She did not suffer from any immunocompromising disease other than severe acute liver failure. She did not survive the disease, although she received appropriate antifungal treatment. We also performed a systematic review of the literature on pulmonary mucormycosis, with or without dissemination, in immunocompetent patients. We found 16 cases of pulmonary or disseminated mucormycosis in immunocompetent patients. Fifty-seven percent of them died and none occurred after an acute liver failure episode. This case report is the first one to present an invasive pulmonary mucormycosis infection after acute liver failure in an adult patient. The clinical course of this disease is highly lethal, even in immunocompetent adults.

Identifiants

pubmed: 31881411
pii: S0883-9441(19)31549-7
doi: 10.1016/j.jcrc.2019.12.012
pii:
doi:

Substances chimiques

Antifungal Agents 0
Acetaminophen 362O9ITL9D

Types de publication

Case Reports Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

89-93

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None of the authors have any conflict of interest to declare.

Auteurs

Yu Qing Huang (YQ)

Department of Medicine, University of Montreal, Canada.

Jan-Alexis Tremblay (JA)

Department of Medicine, University of Montreal, Canada.

Hugo Chapdelaine (H)

Department of Medicine, Division of Immunology, University of Montreal Hospital Centre, Canada; University of Montreal Hospital Research Center, Canada; Montreal Clinical Research Institute, Canada.

Me-Linh Luong (ML)

University of Montreal Hospital Research Center, Canada; Department of Medicine, Division of Infectious diseases, University of Montreal Hospital Centre, Canada.

François Martin Carrier (FM)

University of Montreal Hospital Research Center, Canada; Department of Anesthesiology and Department of Medicine, Division of Critical Care, University of Montreal Hospital Centre, Canada. Electronic address: francois.martin.carrier@umontreal.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH